Thalassemia Screening programs are available to identify thalassemia patients among the general public. Couples are in particular the target group of screening for early identification of carriers who bear risks of having children with thalassemia. Screenings targeted at them are done by detecting heterozygotes in the thalassemia gene. Whereas screening of fetus is done by one-tube osmotic fragility test (identification of red blood cells resistance to hemolysis), red blood cell tests (measurement of mean corpuscular volume and mean corpuscular haemoglobin) or dischlorophenol indophenol precipitation tests (detection of mutation).
Transfusion-dependent anemia
Post-transfusion purpura
Acute hemolytic transfusion reaction
Acquired hemolytic anemia
Delayed hemolytic transfusion reaction
Acute posthemorrhagic anemia
Mixed autoimmune hemolytic anemia
Mechanical hemolytic anemia